Background technology
Lung cancer is modal malignant tumour in world wide, and M & M occupies first of each cancer.The annual whole world has the patient over 1,300,000 to die from lung cancer.At China's lung cancer mortality, be 30.83/10 ten thousand, lung cancer has become the primary malignant tumour of China's M & M.(Orras JM,Fernandez E,Gonzalez JR,et al.Lung cancer mortality in European regions(1955-1997).Ann Oncol,2003,14(1):159)。
5 years survival rates at developed country's patients with lung cancer can reach 20% left and right, and 5 years survival rates of China's patients with lung cancer are only 13%, its major cause is that most of lung cancer is owing to lacking high-sensitive detection in Gene Mutation and making a definite diagnosis technology, thereby make patient cannot accept in time the treatment plan of science, and then make patient miss the best moment for the treatment of.
Chemotherapy is still lung cancer primary treatment means at present, yet most chemotherapy can produce larger toxic side effect, and the chemotherapy effect between different patients also has larger difference.Along with the development of tumour molecular diagnostic techniques, the molecular targeted therapy of lung cancer because of its toxic side effect low, specificity is high, day by day becomes the first-selected therapeutic modality of clinician.The patients with lung cancer that is found to be of new fusion gene ROS1 provides new treatment target spot.ROS1 is a kind of receptor type tyrosine kinase (Receptor Tyrosine Kinase) of Insulin Receptor Family; first ROS 1 fusion is found in glioblastoma, and it merges sudden change and betides karyomit(e) q22 district (Birchmeier et al.Proc Natl Acad Sci.87 (12): 1990 No. 6; Charest et al.Genes Chromosomes Cancer.37:58,2003).ROS1 fusion comprises a complete Tyrosylprotein kinase region, and it merges sudden change can cause the activation of cell downstream signal path, thereby affects the growth of cell, propagation and differentiation.Up-to-date research shows that ROS1 is that a kind of new tumour drives mutator gene, and its fusion is decided to be a kind of new molecular isoform in nonsmall-cell lung cancer.
Clinical studies show small molecules targeted drug Crizotinib(Crizotinib, Pfizer) can in ROS1 gene fusion, suddenly change by specific action, by suppressing the activity in ROS1 Tyrosylprotein kinase region, block its downstream abnormal signal path, thus the growth of inhibition tumor cell.Therefore, detecting ROS1 fusion mutation status is the prerequisite that instructs targeted drug Crizotinib medication, before chemotherapy, by high-sensitive detection method, detect the sudden change of ROS1 fusion gene for the survival rate that improves patients with lung cancer, extend lifetime, avoid excessive chemotherapy, improve life quality important in inhibiting.
The detection method that at present, can detect clinically fusion gene sudden change is mainly real time fluorescent PCR method and direct sequencing.Yet the sensitivity of direct Sequencing is low, detection sensitivity only has 20-30%; Detect complicated operation, efficiency is low, conventionally wants 1-2 talent can go out detected result.Thereby direct sequencing cannot meet the demand of clinical detection reality, clinical in developing a kind of rapid fusion gene tester, to realize, adopt detection method fast to detect merging sudden change simultaneously.
At present, also there is no detection method and the detection kit of ROS1 fusion gene sudden change, the present invention develops a kind of ROS1 fusion gene mutation detection kit and detection method quick, easy and simple to handle first.This detection method can once detect 4 kinds of fusion sudden changes that ROS1 gene produces simultaneously, and detection sensitivity is high, only needs detection time within 90 minutes, can complete, possessed highly sensitive simultaneously, fast cheap, simple operation and other advantages, can meet the actual demand of clinical rapid detection.
Summary of the invention
The object of the present invention is to provide and a kind ofly for ROS1 gene fusion sudden change, detect primer and probe, or have identity nucleotide sequence with it, this detection kit comprises following primer and probe sequence:
Table 1.ROS1 merges mutant primer and probe nucleotide sequence
SL-RO-M1-F1 GGAGATTGATTTTACTTCTCGGATTTCTCTAC SEQ ID NO:1
SR-M1 SL-RO-M1-R1 CCCTTCTAGTAATTTGGGAATGCCTGG SEQ ID NO:2
SR-M2 SL-RO-M2-R1 CCAACTATAATAGTAAGTATGAAACTTGTTTCTGGTATCC SEQ ID NO:3
SL-RO-M1-P1 5-FAM-CTCCAACCAGCTGGAAGGCGCTAC-3-BHQ1 SEQ ID NO:4
CD-RO-M1-F2 GAAATGAGCAGGCACTCCTTGGAG SEQ ID NO:5
CR-M1CD-RO-M1-R1 CCCTTCTAGTAATTTGGGAATGCCTGG SEQ ID NO:6
CR-M2CD-RO-M2-R1 CCAACTATAATAGTAAGTATGAAACTTGTTTCTGGTATCC SEQ ID NO:7
CD-RO-M1-P1 5-FAM-CCCACTGACGCTCCACCGAAAG-3-BHQ1 SEQ ID NO:8
" identity nucleotide sequence " described herein is illustrated in the oligonucleotide of (under maximum stringency condition) and target hybridization under stringent condition, and have that suitable Nucleotide inserts or deletion condition under while contrasting, at the Nucleotide at least about 60% of Nucleotide, be same as above-mentioned nucleotide fragments.More preferably, for thering is the Nucleotide of 80% identity, best, for thering is the Nucleotide of 90% identity.
Hybridization conditions is divided according to the stringency degree of when hybridization condition used, stringency degree can nucleic acid in conjunction with mixture or probe melting temperature(Tm) (Tm) be foundation.For example, " maximum stringency " is Tm-5 ℃ (lower than 5 ℃ of probe Tm); " high stringency " occurs in the following about 5-10 ℃ of Tm; " medium stringency " occurs in the following about 10-20 ℃ of Tm; Low stringency occurs in the following about 20-25 ℃ of Tm.
In the present invention, " identity " refer to, when two kinds or above sequence or subsequence compare, identical or have identical Nucleotide or an amino-acid residue of particular percentile.For determining that the algorithm of sequence identity and sequence similarity percentage ratio is according to BLAST or BLAST2.0 algorithm, they are open in Publication about Document respectively: (1990) J.Mol.Biol.215:403-410. such as (1977) Nucl.Acid.res.25:3389-3402 such as Altschul and Altschul
It is a kind of for detection of ROS1 gene fusion mutation detection kit that the present invention provides on the other hand, and its PCR reaction amplification system is as follows:
The present invention provides a kind of method for mRNA reverse transcription cDNA on the other hand, and method comprises reverse transcription composing system and following operation steps: mRNA reverse transcription cDNA system comprises following composition:
(a) get reverse transcription reaction mixed solution 18 μ l, M-MLV reversed transcriptive enzyme 1 μ l, adds in aseptic centrifuge tube, mixes.
(b) add testing sample RNA 6 μ l, RNA total amount within the scope of 0.1 ~ 5 μ g, moisturizing to 25 μ l.
(c) 42 ℃ are incubated 1 hour.
(d) 95 ℃ insulation 5 minutes after cooled on ice, obtain cDNA template..
It is a kind of for detection of ROS1 gene fusion mutation method that further aspect of the present invention provides, and its method comprises the following steps:
(1) mankind ROS1 announcing according to COSMIC data is wild type gene sequence, for 4 kinds of ROS1 genes, merges sudden change, designs special primer and probe.
(2) extract the RNA that detects sample, detect sample and comprise fresh pathological tissue and paraffin-embedded tissue.
(3) preparation real-time fluorescence PCR amplification reaction system.
(4) the Ct value judgement detected result showing according to fluorescent PCR amplification instrument: the FAM of detection reaction system and HEX fluorescence intensity, when the FAM of usining reaches the threshold value of setting, needed cycle index Ct value is as yin and yang attribute criterion, and Ct value is more than or equal to 30: feminine gender; Ct value is less than 30: the positive.
The invention has the beneficial effects as follows: the present invention has adopted special primer and probe technique, can the sudden change of specific detection mankind ROS1 gene fusion.This method: (1) has set up real-time fluorescence PCR system, can detect 4 kinds of ROS1 genes simultaneously and merge sudden change; (2) highly sensitive, the sudden change of 10-20 copy can detect; (3) simple to operate, detect cheapness, clinical application range is wide; (4) pattern detection scope is wide, and sample can be fresh pathological tissue, paraffin-embedded tissue; (5) detection speed is fast, and testing process only needs to complete for 90 minutes.
Embodiment
It is template that the mutant plasmid that genetically engineered builds is take in the present invention, build ROS1 real-time fluorescence PCR amplification reaction system, take FAM as jump signal sense channel, for ROS1, merge 4 sites design specific probes of sudden change and primer, the optimization by primer and detection system realizes highly sensitive specific detection.The method that detects the sudden change of R0S1 gene fusion comprises the following steps:
(1) for mutational site design synthetic primer and probe:
The mankind ROS1 gene order of announcing according to COSMIC database is wild-type sequence, merges sudden change design Auele Specific Primer and probe for 4 kinds of ROS1 genes.By Auele Specific Primer and probe system optimization, realize highly sensitive and specific detection, 4 of R0S1 genes merge mutational site in Table 2.
For 4 selected fusion mutational sites, application Premier 6.0 primer-design softwares design multipair special primer and many probes, and primer and probe sequence are as shown in table 1.
Table 2.ROS1 gene fusion detection site
(2) extraction of sample process and RNA:
The extraction of sample preparation and RNA: the sample scope of application comprises fresh tumor tissues and paraffin-embedded tissue.Fresh pathological tissue, gets 1 gram of left and right, uses the RNA extraction test kit of TIANGEN to extract its RNA.Paraffin-embedded tissue, is used the RNA extraction test kit of organizing of Qiagen to extract its RNA.Above-mentioned concrete operation step is pressed the operation of test kit specification sheets.
(3) set up pcr amplification reaction system:
By put on and state RNA and be dissolved in 0.1%DEPC water, through UV spectrophotometer measuring, extract quality, determine that its concentration OD260/OD280 is 1.9-2.1, and read its content.Get the RNA of 0.1 ~ 5 μ g as the synthetic template of its cDNA, adopt the synthetic cDNA of test kit of Xiamen Amoydx Bio-Pharmaceutical Technology Co., Ltd., synthetic cDNA system is as follows:
Apply above-mentioned reverse transcription system and carry out as follows reverse transcription:
(a) get reverse transcription reaction mixed solution 18 μ l, M-MLV reversed transcriptive enzyme 1 μ l, adds in aseptic centrifuge tube, mixes.
(b) add testing sample RNA 6 μ l, RNA total amount within the scope of 0.1 ~ 5 μ g, moisturizing to 25 μ l.
(c) 42 ℃ are incubated 1 hour.
(d) 95 ℃ insulation 5 minutes after cooled on ice, obtain cDNA template..
By above-mentioned gained cDNA template, as the template of real-time fluorescence PCR amplification, according to following amplification system, carry out pcr amplification:
Real-time PCR reactions condition is 95 ℃ of denaturations 5 minutes, 1 circulation; 95 ℃ of sex change 25 seconds, 64 ℃ of annealing 20 seconds, 72 ℃ are extended 20 seconds, 15 circulations; 93 ℃ of sex change 25 seconds, 60 ℃ of annealing 35 seconds, 72 ℃ are extended 20 seconds, 31 circulations.Latter 31 circulate in when annealing and detect FAM and HEX or ROX fluorescent signal.
(4) detect fluorescent signal, the standard as a result of judging according to Ct value:
Detect FAM fluorescent signal Ct value, the Ct value judged result showing according to fluorescent PCR amplification instrument: the FAM fluorescence intensity of detection reaction system, when the FAM of usining reaches the threshold value of setting, needed cycle index Ct value is as yin and yang attribute criterion, and Ct value is more than or equal to 30: feminine gender; Ct value is less than 30: the positive.
Below in conjunction with specific embodiment, the present invention is further set forth.Should be understood that these embodiment are only not used in and limit the scope of the invention for the present invention.Unless otherwise defined or described herein, the scientific and technical term described in this patent is understood and is had identical implication with those of ordinary skills.
Embodiment 1
Use system detection plasmid of the present invention, plasmid template for experiment (merging containing ROS1), utilizes the method for above-mentioned fluorescent PCR detection R0S1 gene fusion sudden change as follows:
(1) plasmid is processed and is extracted:
The extraction of plasmid adopts TIANGEN(HighPure Plasmid Kit, DP116) plasmid extraction kit extract, specifically extract operation steps and operate by test kit specification sheets.The DNA that carries is dissolved in (10mmol/L, PH8.0) in Tris-HCl, through UV spectrophotometer measuring, extracts quality, determine its concentration, then use Tris-HCl(10mmol/L, PH 8.0) solution adjust DNA concentration to 2ng/ μ L as pcr template, get 5 μ L and carry out PCR reaction amplification.
(2) set up pcr amplification reaction system:
By above-mentioned gained cDNA template, as the template of real-time fluorescence PCR amplification, according to following amplification system, carry out pcr amplification
Real-time PCR reactions condition is 95 ℃ of denaturations 5 minutes, 1 circulation; 95 ℃ of sex change 25 seconds, 64 ℃ of annealing 20 seconds, 72 ℃ are extended 20 seconds, 15 circulations; 93 ℃ of sex change 25 seconds, 60 ℃ of annealing 35 seconds, 72 ℃ are extended 20 seconds, 31 circulations.Latter 31 circulate in when annealing and detect FAM and HEX or ROX fluorescent signal.
(4) detect fluorescent signal, the standard as a result of judging according to Ct value:
Adopt MX3000P real-time fluorescence PCR instrument to increase, detect the fluorescent signal of FAM and HEX in rear 31 cycle annealing stages, when the FAM of usining reaches the threshold value of setting, needed cycle index Ct value is as yin and yang attribute criterion, and Ct value is more than or equal to 30: feminine gender; Ct value is less than 30: the positive
Sensitivity analysis: after learning from else's experience quantitatively, concentration is the sample DNA of 1000 copies, carries out 10 times of dilutions, then respectively 3 concentration is detected, and every secondary response adds 5 μ L DNA.Result shows the highly sensitive of fluorescence PCR method of the present invention, and 10 copy DNA genomes can detect, and result is as Fig. 2.
Replica test: each reaction adds respectively mutant plasmid DNA1000 copy, 100 copies, repeats to carry out fluorescent PCR amplification 10 times, and 10 times Ct value differs less than 0.5 circulation.
Detected result shows, detection system of the present invention can accurately detect plasmid and detect R0S1 and merge sudden change, and the sensitivity of detection can reach 5-10 copy.
Embodiment 2
Use the present invention to detect clinical lung cancer paraffin-embedded tissue sample, the direct sequencing of learning from else's experience detects definite ROS1 and merges positive 4 example and 11 routine ROS1 wild-type samples, and the R0S1 fusion gene that utilizes special primer of the present invention and fluorescence probe PCR system the to detect 15 routine clinical samples step of suddenling change is as follows:
(1) extraction of sample process and RNA:
(a) get above-mentioned each lung cancer sample, add respectively 1ml dimethylbenzene, mix, the centrifugal 2min of 14000RPM under room temperature, abandon supernatant liquor, add 1ml dehydrated alcohol in precipitation, concussion mixes (removal dimethylbenzene), under room temperature, the centrifugal 2min of 14000RPM abandons supernatant liquor, opens centrifuge tube lid, and 37 ℃ are dried;
(b) in centrifuge tube, add 150 μ l Buffer PKD and 10 μ l Proteinase Ks, concussion mixes, hatch 15min for 56 ℃, hatch 15min for 80 ℃, after dropping to room temperature, add 16ul DNase Booster Buffer and 10ul DNaseI stoste, incubated at room 15min, after add 320 μ l Buffer RBC, mix;
(c) toward supernatant liquor, add 720 μ l dehydrated alcohols, mix, get 700 μ l samples and comprise that the precipitation generating transfers in the RNA MinElute centrifugal column with 2ml collection tube above, be greater than 10, the centrifugal 15s of 000rpm, abandon waste liquid, repeat previous step until sample is transferred in RNA MinElute centrifugal column.
(d) uncap adds 500 μ l Buffer RPE, covers tightly lid, is greater than the centrifugal 2min of 10000rpm, and posts transfer, in collection tube, is dripped to 14-30 μ l RNase-free water to adsorption film middle part, after centrifugal 1min, collects RNA.
(2) set up pcr amplification reaction system:
By put on and state RNA and be dissolved in 0.1%DEPC water, through UV spectrophotometer measuring, extract quality, determine that its concentration OD260/OD280 is 1.9-2.1, and read its content.Get the RNA of 0.1 ~ 5 μ g as the synthetic template of its cDNA, adopt the synthetic cDNA of test kit of Xiamen Amoydx Bio-Pharmaceutical Technology Co., Ltd., cDNA synthetic system is as follows:
Apply above-mentioned reverse transcription system and carry out as follows reverse transcription:
(a) get reverse transcription reaction mixed solution 18 μ l, M-MLV reversed transcriptive enzyme 1 μ l, adds in aseptic centrifuge tube, mixes.
(b) add testing sample RNA 6 μ l, RNA total amount within the scope of 0.1 ~ 5 μ g, moisturizing to 25 μ l.
(c) 42 ℃ are incubated 1 hour.
(d) 95 ℃ insulation 5 minutes after cooled on ice, obtain cDNA template..
By above-mentioned gained cDNA template, as the template of real-time fluorescence PCR amplification, according to following amplification system, carry out pcr amplification:
Real-time PCR reactions condition is 95 ℃ of denaturations 5 minutes, 1 circulation; 95 ℃ of sex change 25 seconds, 64 ℃ of annealing 20 seconds, 72 ℃ are extended 20 seconds, 15 circulations; 93 ℃ of sex change 25 seconds, 60 ℃ of annealing 35 seconds, 72 ℃ are extended 20 seconds, 31 circulations.Latter 31 circulate in when annealing and detect FAM and HEX or ROX fluorescent signal.
(4) detect fluorescent signal, the standard as a result of judging according to Ct value:
Detect FAM fluorescent signal Ct value, the Ct value judged result showing according to fluorescent PCR amplification instrument: the FAM fluorescence intensity of detection reaction system, when the FAM of usining reaches the threshold value of setting, needed cycle index Ct value is as yin and yang attribute criterion, and Ct value is more than or equal to 30: feminine gender; Ct value is less than 30: merge positive
Detected result show detect and in 15 routine lung cancer samples, have 4 examples have ROS1 to merge sudden change, the concordance rate of the sensitivity of this fluorescence PCR method and sequencing detection method is 100%, has further proved and the accuracy of system detection of the present invention the results are shown in Table 3.
Table 3. detected result of the present invention and direct sequencing comparison